A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
Clinical trial NCT05703204 · UNKNOWN
Trial details
- NCT number
- NCT05703204
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2024-08-21
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.